AIMS
- Advocate: For the interests of the psychedelic community.
- Represent: Provide an informed and balanced public voice for the psychedelic community in political and social forums.
- Engage: Facilitate the creation and delivery of resources to strengthen community education, cohesion and direction with a focus on reducing harms and maximising benefits.
- Educate: Help to educate the community on evidence-informed effects and best-practice. Seeking to reduce the stigma associated with drugs in the wider community, using an evidence-based approach.
- Network: provide a hub from which related groups can meet and coordinate, creating greater cohesion and power from which social change can arise.
Events
APS Sydney presents – DR BRUCE DAMER
A Visionary Approach for Hope and Action in the Era of Climate Shock Dr. Bruce Damer is a scientist, designer and public intellectual working on the key question of how life started on the Earth and the future of humanity as we expand into space. He holds post in Biomolecular Engineering at the University of […]
Continue reading
News
Esketamine Approved by the FDA for Treatment Resistant Depression
Marco Stojanovik Following a review of clinical trial results and consultation with external advisors, the Food and Drug Administration (FDA) has granted approval for Spravato to be used in patients with treatment-resistant depression in the United States. Spravato is a nasal spray produced by Janssen Pharmaceuticals Inc. that contains esketamine hydrochloride, a chemical mirror to […]
Continue readingLocal Network
